Clinical data | |
---|---|
Other names | N-propyl-1-phenyl-propan-2-amine; N-propylamphetamine |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.215.934 ![]() |
Chemical and physical data | |
Formula | C12H19N |
Molar mass | 177.291 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Propylamphetamine is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes which acts as a stimulant. It was first developed in the 1970s, mainly for research into the metabolism of,[1] and as a comparison tool to, other amphetamines.[2] A study in rats found propylamphetamine to be 1/4 as potent as amphetamine.[3]
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|